PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+25.21%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$13.9M
AUM Growth
+$13.9M
(-75%)
Cap. Flow
-$45.4M
Cap. Flow
% of AUM
-326.16%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
83
New
14
Increased
3
Reduced
23
Closed
37
Top Buys
| 1 |
Biogen
BIIB
|
$546K |
| 2 |
Elevance Health
ELV
|
$504K |
| 3 |
Humana
HUM
|
$494K |
| 4 |
Centene
CNC
|
$430K |
| 5 |
Pfizer
PFE
|
$294K |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
$2.23M |
| 2 |
Microchip Technology
MCHP
|
$2.23M |
| 3 |
Zimmer Biomet
ZBH
|
$2.09M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$2.03M |
| 5 |
Twilio
TWLO
|
$1.74M |
Sector Composition
| 1 | Healthcare | 91.76% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
26
DELISTED
Immunomedics Inc
IMMU
| $230K | 1.65% |
+10,880
| New | +$230K |
|
27
Abbott
ABT
$229B
| $223K | 1.6% |
+2,565
| New | +$223K |
|
28
Molina Healthcare
MOH
$9.93B
| $188K | 1.35% |
1,387
-5,796
| -81% | -$786K |
|
29
Edwards Lifesciences
EW
$48B
| $184K | 1.32% |
788
-2,931
| -79% | -$684K |
|
30
Standard BioTools
LAB
$474M
| $132K | 0.95% |
37,856
+2,504
| +7% | +$8.73K |
|
|
CTLT
31
DELISTED
CATALENT, INC.
CTLT
| $126K | 0.9% |
2,231
-11,331
| -84% | -$640K |
|
32
AbbVie
ABBV
$374B
| $112K | 0.8% |
+1,269
| New | +$112K |
|
|
AXNX
33
DELISTED
Axonics, Inc. Common Stock
AXNX
| $110K | 0.79% |
3,978
+2,041
| +105% | +$56.4K |
|
|
CSII
34
DELISTED
Cardiovascular Systems, Inc.
CSII
| $96K | 0.69% |
1,985
-3,930
| -66% | -$190K |
|
35
Vertex Pharmaceuticals
VRTX
$103B
| $95K | 0.68% |
+434
| New | +$95K |
|
36
Halozyme
HALO
$8.58B
| $82K | 0.59% |
+4,650
| New | +$82K |
|
|
AMRN
37
Amarin Corp
AMRN
$314M
| $81K | 0.58% |
+3,757
| New | +$81K |
|
38
Coherus Oncology, Inc. Common Stock
CHRS
$138M
| $68K | 0.49% |
3,771
-4,035
| -52% | -$72.8K |
|
|
ACOR
39
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $37K | 0.27% |
18,342
-1,536
| -8% | -$3.1K |
|
|
ELGX
40
DELISTED
Endologix Inc
ELGX
| $4K | 0.03% |
2,440
-442
| -15% | -$725 |
|
41
Advanced Micro Devices
AMD
$263B
| – | – |
-25,859
| Closed | -$750K |
|
42
Alibaba
BABA
$330B
| – | – |
-2,532
| Closed | -$423K |
|
43
Salesforce
CRM
$242B
| – | – |
-10,032
| Closed | -$1.49M |
|
44
DexCom
DXCM
$29.1B
| – | – |
-5,323
| Closed | -$794K |
|
45
Equillium
EQ
$61.4M
| – | – |
-5,333
| Closed | -$20K |
|
46
Fate Therapeutics
FATE
$119M
| – | – |
-8,899
| Closed | -$138K |
|
47
GoDaddy
GDDY
$20B
| – | – |
-21,910
| Closed | -$1.45M |
|
48
Goldman Sachs
GS
$221B
| – | – |
-1,562
| Closed | -$324K |
|
49
Inspire Medical Systems
INSP
$2.8B
| – | – |
-3,549
| Closed | -$217K |
|
50
Intuit
INTU
$185B
| – | – |
-5,722
| Closed | -$1.52M |
|